Polycystic ovary syndrome is associated with endothelial dysfunction.
about
Lifestyle changes in women with polycystic ovary syndromeLifestyle changes in women with polycystic ovary syndromeLifestyle changes in women with Polycystic Ovary SyndromeComplications and challenges associated with polycystic ovary syndrome: current perspectivesEndothelial progenitor cell dysfunction in polycystic ovary syndrome: implications for the genesis of cardiovascular diseasesPolycystic Ovary Syndrome: Important Underrecognised Cardiometabolic Risk Factor in Reproductive-Age WomenDoes endothelial dysfunction correlate with endocrinal abnormalities in patients with polycystic ovary syndrome?The vascular endothelium and human diseasesScientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.The importance of speckle tracking echocardiography in the early detection of left ventricular dysfunction in patients with polycystic ovary syndrome.Androgen supplementation in older women: too much hype, not enough data.Microvascular dysfunction in women with polycystic ovary syndrome.Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.Endothelial dysfunction as a target for prevention of cardiovascular disease.Polycystic ovarian syndrome: diagnosis and management.Statins in the treatment of polycystic ovary syndrome.Severe impairment of endothelial function with the HIV-1 protease inhibitor indinavir is not mediated by insulin resistance in healthy subjects.Nonalcoholic fatty liver disease and polycystic ovary syndrome.MECHANISMS IN ENDOCRINOLOGY: The sexually dimorphic role of androgens in human metabolic disease.Cardiovascular disease markers in women with polycystic ovary syndrome with emphasis on asymmetric dimethylarginine and homocysteine.A combined oral contraceptive containing 30 mcg ethinyl estradiol and 3.0 mg drospirenone does not impair endothelium-dependent vasodilation.Estrogen, medroxyprogesterone acetate, endothelial function, and biomarkers of cardiovascular risk in young women.Obstructive sleep apnea and metabolic dysfunction in polycystic ovary syndromePolycystic ovary syndrome in the pediatric populationEvidence for increased cardiovascular events in the fathers but not mothers of women with polycystic ovary syndromeAssociation of mean platelet volume with androgens and insulin resistance in nonobese patients with polycystic ovary syndrome.Implications for reproductive medicine: Sex differences in cardiovascular diseaseComparison of Biomedical Variables in PCOS Patients with Normal Iranian WomenEvaluation of early atherosclerotic findings in women with polycystic ovary syndrome.Cardiovascular risk in women with polycystic ovarian syndrome (PCOS)Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease.The management of polycystic ovary syndrome.Conservative management of gynecologic diseases: insulin sensitizing agents in polycystic ovary syndrome.The pathophysiology of polycystic ovary syndrome.Association Study between Polycystic Ovarian Syndrome and the Susceptibility Genes Polymorphisms in Hui Chinese Women.Is PCOS an inflammatory process?Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or ObesityEndothelial dysfunction, inflammation, and insulin resistance: a focus on subjects at risk for type 2 diabetes.Insulin resistance in patients with polycystic ovary syndrome.Cardiovascular Protective Effect of Metformin and Telmisartan: Reduction of PARP1 Activity via the AMPK-PARP1 Cascade
P2860
Q24234000-E873F9F0-2C1F-4E75-9FF3-2694B67FA754Q24235398-7C01B70A-7418-413A-AC8F-CBAC5F58DE2AQ24242021-E124D427-6587-4193-90E9-302ED2520995Q26799566-5A35D98F-4C2F-4E0F-BEC9-D5AC155E8117Q26851688-E5D3657D-0BAB-47B2-AB2F-535096105775Q27021307-7B54026A-3E50-4F49-8286-264CEBCB989AQ28079172-B564E261-CC12-4049-A0D4-4A726BABDCC7Q28302238-B923AC50-5919-49DC-B06F-22A6D748DE2EQ28390200-3D34E9ED-2864-4149-A309-49BCD5CCC140Q30394402-AA7F20EA-BBB6-4A87-86AF-4D783D48C067Q30702926-0D504E89-D299-49B7-9D03-431C5468C836Q33220101-6F40BF06-776A-48C1-B448-ED27F6472EAAQ33569169-36B6C12F-0902-49FB-A8F8-4EE6E27B5895Q33610670-60DCEE4F-E3AD-40F2-98A2-98E43BF9534FQ33723471-C4DD619B-3D4A-4436-8AB9-9DF19CDFBE59Q33789151-411B57A8-999E-4F96-A1BC-259A8628F59FQ33816114-609B086F-55C8-4BFF-8BC9-031E55D5DF56Q33886930-479D441D-BABC-460C-AAF4-BD0D7677B1CFQ33904576-04C5FEF9-59EA-44B5-ACE8-A6622DD990D2Q34099243-04036937-030A-49A6-9975-A39026D7F865Q34145361-896D579D-F23C-4B13-B4A5-9F6113491346Q34447831-7E1E8645-0386-4F49-BCB8-B778067419C5Q34536081-0AE1CFF2-84C4-44AC-A99C-F8C662CBD449Q35075035-FD173609-9114-495D-B56D-28EAD6A7100AQ35108260-0D60B56F-9BB0-479A-9A98-2214150C1187Q35114712-FFE7F2FF-0E3D-44D1-95C4-55F5127239D1Q35205039-A06EBB68-E21B-4DE6-BDFD-1C649A28ED9BQ35514992-8D4DA201-FFDC-426D-BDC5-CD9E12B4E3ECQ35540579-8F1CB7A6-2AFA-4D61-9DD3-7BC6FF7064F7Q35588340-63F86FE7-E215-473F-A11F-612E003CC8A1Q35588998-2BBD0293-1387-4473-B321-B34471252676Q35596279-385D01DC-D6A1-4FE7-818F-6B228B8AD40AQ35596283-99D9AC8D-3C85-4D96-A4EA-ECF198AB777DQ35608887-7C6D896A-5DA5-4664-A922-9175CEF21EF4Q35610730-A7F2EDBD-59F0-4B09-8346-62606814109DQ35633277-118BF216-18D7-49A6-B455-C5DA7480635AQ35675962-E49437E6-75D7-441D-82FB-53BBAE950245Q35841788-B78318CE-45AB-4246-BA91-A7782C195CFFQ35932352-9593231E-86BC-4657-A5D6-355DE7D48AFCQ35961020-349511FD-9580-4E76-BE43-72FA2F626219
P2860
Polycystic ovary syndrome is associated with endothelial dysfunction.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Polycystic ovary syndrome is associated with endothelial dysfunction.
@en
Polycystic ovary syndrome is associated with endothelial dysfunction.
@nl
type
label
Polycystic ovary syndrome is associated with endothelial dysfunction.
@en
Polycystic ovary syndrome is associated with endothelial dysfunction.
@nl
prefLabel
Polycystic ovary syndrome is associated with endothelial dysfunction.
@en
Polycystic ovary syndrome is associated with endothelial dysfunction.
@nl
P2093
P1433
P1476
Polycystic ovary syndrome is associated with endothelial dysfunction.
@en
P2093
Hempfling A
Paradisi G
Shepard MK
Steinberg HO
P304
P356
10.1161/01.CIR.103.10.1410
P407
P577
2001-03-01T00:00:00Z